{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:23:33Z","timestamp":1792427013714,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471199"],"award-info":[{"award-number":["82471199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05341-2","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:48:13Z","timestamp":1763174893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CSF Glucose-6-Phosphate Isomerase Is a Tau-Related Biomarker Associated with Neurodegeneration and Cognitive Impairment in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Yuhan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Ju","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"5341_CR1","doi-asserted-by":"crossref","unstructured":"(2024) 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20:3708\u20133821","DOI":"10.1002\/alz.13809"},{"key":"5341_CR2","doi-asserted-by":"publisher","first-page":"e70388","DOI":"10.1002\/brb3.70388","volume":"15","author":"I Tam","year":"2025","unstructured":"Tam I, Wang K (2025) Prevalence of cognitive impairment\/dementia and associated risks factors among community-dwelling elderly people aged 65 or above in the community centers in Hong Kong: a cross-sectional study. Brain Behav 15:e70388","journal-title":"Brain Behav"},{"key":"5341_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","volume":"23","author":"FG De Felice","year":"2022","unstructured":"De Felice FG, Gon\u00e7alves RA, Ferreira ST (2022) Impaired insulin signalling and allostatic load in Alzheimer disease. Nat Rev Neurosci 23:215\u2013230","journal-title":"Nat Rev Neurosci"},{"key":"5341_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590","journal-title":"Lancet"},{"key":"5341_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT et al (2021) Alzheimer disease. Nat Rev Dis Primers 7:33","journal-title":"Nat Rev Dis Primers"},{"key":"5341_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339","journal-title":"Cell"},{"key":"5341_CR7","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20:5143\u20135169","journal-title":"Alzheimers Dement"},{"key":"5341_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32","journal-title":"Mol Neurodegener"},{"key":"5341_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41398-025-03347-x","volume":"15","author":"JH Hou","year":"2025","unstructured":"Hou JH, Jiang DM, Chu M, Wu LY (2025) Blood-brain barrier biomarkers modulate the associations of peripheral immunity with Alzheimer\u2019s disease. Transl Psychiatry 15:138","journal-title":"Transl Psychiatry"},{"key":"5341_CR10","doi-asserted-by":"publisher","first-page":"102341","DOI":"10.1016\/j.arr.2024.102341","volume":"98","author":"F Zhang","year":"2024","unstructured":"Zhang F, Zhang W (2024) Research progress in Alzheimer\u2019s disease and bone-brain axis. Ageing Res Rev 98:102341","journal-title":"Ageing Res Rev"},{"key":"5341_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s40001-024-01918-0","volume":"29","author":"H Shi","year":"2024","unstructured":"Shi H, Chen M (2024) The brain-bone axis: unraveling the complex interplay between the central nervous system and skeletal metabolism. Eur J Med Res 29:317","journal-title":"Eur J Med Res"},{"key":"5341_CR12","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1002\/alz.13864","volume":"20","author":"ZT Liu","year":"2024","unstructured":"Liu ZT, Liu MH, Xiong Y, Wang YJ, Bu XL (2024) Crosstalk between bone and brain in Alzheimer\u2019s disease: mechanisms, applications, and perspectives. Alzheimers Dement 20:5720\u20135739","journal-title":"Alzheimers Dement"},{"key":"5341_CR13","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/WNL.0000000000207369","volume":"101","author":"J Du","year":"2023","unstructured":"Du J, Li A, Shi D, Chen X, Wang Q, Liu Z et al (2023) Association of APOE-\u03b54, osteoarthritis, \u03b2-amyloid, and tau accumulation in primary motor and somatosensory regions in Alzheimer disease. Neurology 101:e40\u2013e49","journal-title":"Neurology"},{"key":"5341_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-191311","volume":"75","author":"KE Innes","year":"2020","unstructured":"Innes KE, Sambamoorthi U (2020) The association of osteoarthritis and related pain burden to incident Alzheimer\u2019s disease and related dementias: a retrospective cohort study of U.S. Medicare beneficiaries. J Alzheimers Dis 75:789\u2013805","journal-title":"J Alzheimers Dis"},{"key":"5341_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1742-2094-8-112","volume":"8","author":"S Kyrkanides","year":"2011","unstructured":"Kyrkanides S, Tallents RH, Miller JN, Olschowka ME, Johnson R, Yang M et al (2011) Osteoarthritis accelerates and exacerbates Alzheimer\u2019s disease pathology in mice. J Neuroinflammation 8:112","journal-title":"J Neuroinflammation"},{"key":"5341_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bone.2014.01.010","volume":"61","author":"S Li","year":"2014","unstructured":"Li S, Liu B, Zhang L, Rong L (2014) Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. Bone 61:164\u2013175","journal-title":"Bone"},{"key":"5341_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00190","volume":"12","author":"X Li","year":"2020","unstructured":"Li X, Tong Q, Gao J, Liu C, Liu Y (2020) Osteoarthritis was associated with a faster decline in hippocampal volumes in cognitively normal older people. Front Aging Neurosci 12:190","journal-title":"Front Aging Neurosci"},{"key":"5341_CR18","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.2147\/CMAR.S177441","volume":"10","author":"YT Ma","year":"2018","unstructured":"Ma YT, Xing XF, Dong B, Cheng XJ, Guo T, Du H et al (2018) Higher autocrine motility factor\/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer. Cancer Manag Res 10:4969\u20134980","journal-title":"Cancer Manag Res"},{"key":"5341_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/ard.2004.025502","volume":"64","author":"M Schaller","year":"2005","unstructured":"Schaller M, Stohl W, Tan SM, Benoit VM, Hilbert DM, Ditzel HJ (2005) Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis 64:743\u2013749","journal-title":"Ann Rheum Dis"},{"key":"5341_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep40274","volume":"7","author":"Y Lu","year":"2017","unstructured":"Lu Y, Yu SS, Zong M, Fan SS, Lu TB, Gong RH et al (2017) Glucose-6-phosphate isomerase (G6PI) mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Sci Rep 7:40274","journal-title":"Sci Rep"},{"key":"5341_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ et al (2010) Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization. Neurology 74:201\u2013209","journal-title":"Neurology"},{"key":"5341_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12974-022-02679-5","volume":"19","author":"ZB Wang","year":"2022","unstructured":"Wang ZB, Ma YH, Sun Y, Tan L, Wang HF, Yu JT (2022) Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-\u03b2 and tau pathology in Alzheimer\u2019s disease. J Neuroinflammation 19:316","journal-title":"J Neuroinflammation"},{"key":"5341_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13195-024-01506-8","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ye M, Ji Q, Liu Q, Xu X, Zhan Y (2024) The longitudinal trajectory of CSF sTREM2: the Alzheimer\u2019s disease neuroimaging initiative. Alzheimers Res Ther 16:138","journal-title":"Alzheimers Res Ther"},{"key":"5341_CR24","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T et al (2018) CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement 14:1470\u20131481","journal-title":"Alzheimers Dement"},{"key":"5341_CR25","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV et al (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24:1302\u20131312","journal-title":"Nat Neurosci"},{"key":"5341_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-024-01924-6","author":"Y Guo","year":"2024","unstructured":"Guo Y, Chen SD, You J, Huang SY, Chen YL, Zhang Y et al (2024) Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease. Nat Hum Behav. https:\/\/doi.org\/10.1038\/s41562-024-01924-6","journal-title":"Nat Hum Behav"},{"key":"5341_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216","journal-title":"Lancet Neurol"},{"key":"5341_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnagi.2014.00264","volume":"6","author":"O Voevodskaya","year":"2014","unstructured":"Voevodskaya O, Simmons A, Nordenskj\u00f6ld R, Kullberg J, Ahlstr\u00f6m H, Lind L et al (2014) The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer\u2019s disease. Front Aging Neurosci 6:264","journal-title":"Front Aging Neurosci"},{"key":"5341_CR29","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/trc2.70033","volume":"11","author":"SM Hartz","year":"2025","unstructured":"Hartz SM, Schindler SE, Streitz ML, Moulder KL, Mozersky J, Wang G et al (2025) Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Transl Res Clin Interv 11:e70033","journal-title":"Alzheimer's & Dementia: Transl Res Clin Interv"},{"key":"5341_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16257","author":"YH Chen","year":"2024","unstructured":"Chen YH, Wang ZB, Liu XP, Mao ZQ (2024) Elevated serum sodium is linked to increased amyloid-dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer\u2019s disease. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.16257","journal-title":"J Neurochem"},{"key":"5341_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13195-019-0539-3","volume":"11","author":"MM Ryan","year":"2019","unstructured":"Ryan MM, Grill JD, Gillen DL (2019) Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer\u2019s disease: study partner vs. participant accuracy. Alzheimers Res Ther 11:85","journal-title":"Alzheimers Res Ther"},{"key":"5341_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L et al (2020) Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26:769\u2013780","journal-title":"Nat Med"},{"key":"5341_CR33","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1002\/alz.13413","volume":"19","author":"ZB Wang","year":"2023","unstructured":"Wang ZB, Tan L, Gao PY, Ma YH, Fu Y, Sun Y et al (2023) Associations of the A\/T\/N profiles in PET, CSF, and plasma biomarkers with Alzheimer\u2019s disease neuropathology at autopsy. Alzheimers Dement 19:4421\u20134435","journal-title":"Alzheimers Dement"},{"key":"5341_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ et al (2022) Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther 14:174","journal-title":"Alzheimers Res Ther"},{"key":"5341_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05007-z","author":"YH Chen","year":"2025","unstructured":"Chen YH, Wang ZB, Liu XP, Mao ZQ (2025) Cerebrospinal fluid CCL25 as a biomarker for Alzheimer\u2019s disease: associations with pathology, neurodegeneration, and cognitive decline. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05007-z","journal-title":"Mol Neurobiol"},{"key":"5341_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251326286","author":"YH Chen","year":"2025","unstructured":"Chen YH, Wang ZB, Liu XP, Mao ZQ (2025) Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer\u2019s disease pathology and cognitive decline. J Alzheimers Dis. https:\/\/doi.org\/10.1177\/13872877251326286","journal-title":"J Alzheimers Dis"},{"key":"5341_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"5341_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"5341_CR39","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s12035-018-1174-x","volume":"56","author":"MJ Finelli","year":"2019","unstructured":"Finelli MJ, Paramo T, Pires E, Ryan BJ, Wade-Martins R, Biggin PC et al (2019) Oxidation resistance 1 modulates glycolytic pathways in the cerebellum via an interaction with glucose-6-phosphate isomerase. Mol Neurobiol 56:1558\u20131577","journal-title":"Mol Neurobiol"},{"key":"5341_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s004390050849","volume":"103","author":"W Kugler","year":"1998","unstructured":"Kugler W, Breme K, Laspe P, Muirhead H, Davies C, Winkler H et al (1998) Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency. Hum Genet 103:450\u2013454","journal-title":"Hum Genet"},{"key":"5341_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13024-025-00883-4","volume":"20","author":"BB Holmes","year":"2025","unstructured":"Holmes BB, Weigel TK, Chung JM, Kaufman SK, Apresa BI, Byrnes JR et al (2025) \u03b2-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity. Mol Neurodegener 20:96. https:\/\/doi.org\/10.1186\/s13024-025-00883-4","journal-title":"Mol Neurodegener"},{"key":"5341_CR42","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","volume":"29","author":"K Horie","year":"2023","unstructured":"Horie K, Salvad\u00f3 G, Barth\u00e9lemy NR, Janelidze S, Li Y, He Y et al (2023) CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease. Nat Med 29:1954\u20131963","journal-title":"Nat Med"},{"key":"5341_CR43","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/alz.13539","volume":"20","author":"PM Cogswell","year":"2024","unstructured":"Cogswell PM, Lundt ES, Therneau TM, Wiste HJ, Graff-Radford J, Algeciras-Schimnich A et al (2024) Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. Alzheimers Dement 20:1225\u20131238","journal-title":"Alzheimers Dement"},{"key":"5341_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JAD-240289","volume":"100","author":"YH Chen","year":"2024","unstructured":"Chen YH, Wang ZB, Liu XP, Mao ZQ (2024) Plasma insulin predicts early amyloid-\u03b2 pathology changes in Alzheimer\u2019s disease. J Alzheimers Dis 100:321\u2013332","journal-title":"J Alzheimers Dis"},{"key":"5341_CR45","doi-asserted-by":"publisher","first-page":"102031","DOI":"10.1016\/j.xcrm.2025.102031","volume":"6","author":"Z Wang","year":"2025","unstructured":"Wang Z, Chen Y, Gong K, Zhao B, Ning Y, Chen M et al (2025) Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages. Cell Rep Med 6:102031","journal-title":"Cell Rep Med"},{"key":"5341_CR46","first-page":"1797","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M, Ashton NJ, Shekari M, Salvad\u00f3 G, Ortiz-Romero P, Montoliu-Gaya L et al (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med 28:1797\u20131801","journal-title":"Nat Med"},{"key":"5341_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","volume":"147","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez J, Montoliu-Gaya L, Benedet AL, Vrillon A, Dumurgier J, Cognat E et al (2024) CSF p-tau205: a biomarker of tau pathology in Alzheimer\u2019s disease. Acta Neuropathol 147:12","journal-title":"Acta Neuropathol"},{"key":"5341_CR48","doi-asserted-by":"publisher","first-page":"752642","DOI":"10.3389\/fonc.2021.752642","volume":"11","author":"J Han","year":"2021","unstructured":"Han J, Deng X, Sun R, Luo M, Liang M, Gu B et al (2021) GPI is a prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Front Oncol 11:752642","journal-title":"Front Oncol"},{"key":"5341_CR49","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","volume":"30","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews SJ, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease. Nat Med 30:2121\u20132124","journal-title":"Nat Med"},{"key":"5341_CR50","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1038\/tp.2016.296","volume":"7","author":"E Lauretti","year":"2017","unstructured":"Lauretti E, Li JG, Di Meco A, Pratic\u00f2 D (2017) Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Transl Psychiatry 7:e1020","journal-title":"Transl Psychiatry"},{"key":"5341_CR51","doi-asserted-by":"publisher","first-page":"eabm6131","DOI":"10.1126\/science.abm6131","volume":"385","author":"PS Minhas","year":"2024","unstructured":"Minhas PS, Jones JR, Latif-Hernandez A, Sugiura Y, Durairaj AS, Wang Q et al (2024) Restoring hippocampal glucose metabolism rescues cognition across Alzheimer\u2019s disease pathologies. Science 385:eabm6131","journal-title":"Science"},{"key":"5341_CR52","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/alz.12997","volume":"19","author":"ZB Wang","year":"2023","unstructured":"Wang ZB, Tan L, Wang HF, Chen SD, Fu Y, Gao PY et al (2023) Differences between ante mortem Alzheimer\u2019s disease biomarkers in predicting neuropathology at autopsy. Alzheimers Dement 19:3613\u20133624","journal-title":"Alzheimers Dement"},{"key":"5341_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-021-00834-3","volume":"13","author":"Y Guo","year":"2021","unstructured":"Guo Y, Huang YY, Shen XN, Chen SD, Hu H, Wang ZT et al (2021) Characterization of Alzheimer\u2019s tau biomarker discordance using plasma, CSF, and PET. Alzheimers Res Ther 13:93","journal-title":"Alzheimers Res Ther"},{"key":"5341_CR54","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/s41591-025-03617-7","volume":"31","author":"K Horie","year":"2025","unstructured":"Horie K, Salvad\u00f3 G, Koppisetti RK, Janelidze S, Barth\u00e9lemy NR, He Y et al (2025) Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer\u2019s disease. Nat Med 31:2044\u20132053","journal-title":"Nat Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05341-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:04:10Z","timestamp":1763420650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05341-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5341"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05341-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all ADNI participants, and ADNI received approval from the institutional review boards at all participating institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data used in preparation of this article were obtained from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database (\n                      \n                      ). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and\/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at\n                      \n                      ..","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consortium Name"}}],"article-number":"47"}}